Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1851273Generated: October 30, 2026

Sodium triacetoxyborohydride → 2-methyl-6-phenyl-5-{4-[4-(6-trifluoromethyl-1H-benzimidazol-2-yl)-piperidin-1-ylmethyl]-phenyl}-[1,2,4]-triazolo[1,5-a]pyrimidine

https://huagongshe.com/reaction/1851273

Reaction equation

Participants

RoleNameHCIDCharge
ReactantSodium triacetoxyborohydrideHCID 5049666—
Reactant2-Piperidine-4-yl-6-trifluoromethyl-1h-benzimidazole hydrochloride saltHCID 68752934—
Reactant4-(2-Methyl-6-phenyl[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)benzaldehydeHCID 86630681—
Product2-methyl-6-phenyl-5-{4-[4-(6-trifluoromethyl-1H-benzimidazol-2-yl)-piperidin-1-ylmethyl]-phenyl}-[1,2,4]-triazolo[1,5-a]pyrimidineHCID 6875145730%

Reaction Steps

200 mg (0.64 mmol) 4-(2-methyl-6-phenyl[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)benzaldehyde and 232 mg (0.64 mmol) 2-piperidine-4-yl-6-trifluoromethyl-1H-benzimidazole hydrochloride salt were treated as described in example 2.0. Additional NaBH(OAc)3 has been added after 24 and 26 hours (two equivalents each). After five days stirring at room temperature the solvents have been evaporated and the residue was purified via chromatography. 109 mg of the desired compound were obtained.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08957064B2
Source datasetuspto-grants-2015_02
ORD IDord-4b919ca7771940ce955447a9a7c65036
Source noteuspto-grants-2015_02